Derrell Porter
Direktor/Vorstandsmitglied bei PASSAGE BIO, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Derrell Porter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PASSAGE BIO, INC. | Direktor/Vorstandsmitglied | 27.05.2021 | - |
Independent Dir/Board Member | 27.05.2021 | - | |
ACUMEN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 04.01.2023 | - |
Independent Dir/Board Member | 04.01.2023 | - | |
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Direktor/Vorstandsmitglied | - | - |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Direktor/Vorstandsmitglied | - | - |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Vorstandsvorsitzender | 01.05.2023 | - |
Karriereverlauf von Derrell Porter
Ehemalige bekannte Positionen von Derrell Porter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 10.05.2017 | 01.10.2019 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.04.2013 | 01.05.2017 |
Cellevolve Bio
Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2020 | - |
Gründer | 01.01.2020 | - | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Direktor/Vorstandsmitglied | 03.10.2018 | - |
░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Ausbildung von Derrell Porter
University of California, Los Angeles | Undergraduate Degree |
Perelman School of Medicine | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 14 |
Kanada | 2 |
Operativ
Director/Board Member | 5 |
Sales & Marketing | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 10 |
Consumer Services | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
AMGEN INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
ABBVIE INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
PASSAGE BIO, INC. | Health Technology |
ACUMEN PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Health Technology |
Cellevolve Bio
Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Derrell Porter
- Erfahrung